Loading quotes...
Forecast
The analysts' average price target is €52.32 (+0.13%). The median is €49.89 (-4.52%).
| Buy |
6 |
| Hold |
11 |
| Sell |
0 |
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
CNO Financial relies on operational execution and a $170 million IT modernization as a growth driver
At the KBW Insurance Conference, CNO Financial presented its strategy: growth through higher agent productivity, a broader product mix and a focus on middle-income Americans. Return on equity already exceeds the prior 12% target for 2027, and broker-dealer assets rose to $19 billion in the second quarter. Management plans a three-year technology modernization of about $170 million that should support long-term growth but is likely to produce little near-term earnings. CNO emphasizes organic growth, cross-selling through Medicare products and a shift of direct-to-consumer sales from TV to digital channels. » More on de.investing.com
CNO Financial Group announces quarterly dividend of $0.18
The board of directors of CNO Financial Group has declared a quarterly cash dividend of $0.18 per common share. The payment date is September 24, 2026; the record date is September 10, 2026. This is the insurer's 58th consecutive quarterly dividend; it operates under brands such as Bankers Life and Colonial Penn. » More on de.investing.com
CNO Financial Group reaches new all-time high at $53.61
CNO Financial Group’s stock climbed to a new all-time high of $53.61. Over the past year the share price rose 46% and market capitalization is about $5 billion; the six-month return is 28%. CNO has also increased its dividend for 14 consecutive years. Analysts reacted mixed: Jefferies downgraded the stock from buy to hold but raised the price target to $55, while Evercore upgraded from underperform to in line with a $48 target. At the annual meeting nine directors were re-elected. » More on de.investing.com
CNO Financial Group: shareholders elect nine directors, approve compensation and PwC as auditor
Shareholders of CNO Financial Group elected nine directors to serve until the 2027 annual meeting and approved the disclosed executive compensation in a non-binding vote. PricewaterhouseCoopers was also appointed as the independent auditor for 2026. The company reported strong Q1 results with EPS of $1.05 and revenue of $1.03 billion, beating analysts' expectations; the stock is trading near its 52-week high. » More on de.investing.com
CNO Financial Group reaches record high at $45.85 after strong quarterly results
CNO Financial Group's stock rose to an all-time high of $45.85 after gaining 21.37% last year. For Q1 2026 the company reported earnings per share of $1.05 and revenue of $1.03 billion, both above analyst expectations. InvestingPro rates the stock as undervalued and highlights ongoing dividend increases. Analysts will watch whether the upward momentum continues. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 958.78m | 5.35% |
| Gross profit | 958.78m | 144.65% |
| Net profit | 142.23m | 622.54% |
| EBITDA | 251.17m | 70.48% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €4.76bn |
Number of shares | 91.35m |
52-week high/low | €53.66 - €35.37 |
Dividend yield | 1.16% |
Dividends TTM | €0.61 |
Beta | 0.81 |
P/E ratio | 12.83 |
PEG ratio | 0.24 |
P/B ratio | 2.28 |
P/S ratio | 1.16 |
Company profile
CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on worksite and group sales for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed index annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. CNO Financial Group, Inc. markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company sells its products through agents, independent producers, and direct marketing. CNO Financial Group, Inc. was founded in 1979 and is headquartered in Carmel, Indiana.
| Name | CNO Financial Group |
| CEO | Gary C. Bhojwani |
| Headquarters | Carmel,
in USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| IPO | 10/09/2003 |
| Employees | 3,200 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | CNO |
Frankfurt | COS.F |
Düsseldorf | COS.DU |
SIX | COSCHF.SW |